| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:736636 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GLS mRNA | CTD | PMID:22079256 |
| 1,2,4-trimethylbenzene | decreases expression | ISO | RGD:2707 | 6480464 | pseudocumene results in decreased expression of GLS protein | CTD | PMID:17337753 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:2707 | 6480464 | Ethinyl Estradiol affects the expression of GLS mRNA | CTD | PMID:20170705 |
| 17beta-estradiol | affects expression | ISO | RGD:736636 | 6480464 | Estradiol affects the expression of GLS mRNA | CTD | PMID:22574217 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:736636 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GLS mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:736636 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GLS mRNA | CTD | PMID:20106945 PMID:21632981 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GLS mRNA | CTD | PMID:19770486 |
| 7,12-dimethyltetraphene | increases expression | ISO | RGD:736636 | 6480464 | 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GLS mRNA | CTD | PMID:21527772 |
| acrylamide | increases expression | ISO | RGD:2707 | 6480464 | Acrylamide results in increased expression of GLS mRNA | CTD | PMID:15749267 |
| aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of GLS mRNA | CTD | PMID:19770486 |
| aflatoxin B1 | increases expression | ISO | RGD:736636 | 6480464 | Aflatoxin B1 results in increased expression of GLS mRNA | CTD | PMID:21641981 |
| all-trans-retinoic acid | increases expression | ISO | RGD:736636 | 6480464 | Tretinoin results in increased expression of GLS mRNA | CTD | PMID:21934132 |
| ammonia | multiple interactions | EXP | | 6480464 | [Hydrochloric Acid results in decreased expression of GLS protein] which results in increased secretion of Ammonia; more ... | CTD | PMID:20719974 |
| ammonia | affects secretion | EXP | | 6480464 | GLS protein affects the secretion of Ammonia | CTD | PMID:20719974 |
| ammonium chloride | increases expression | EXP | | 6480464 | Ammonium Chloride results in increased expression of GLS protein | CTD | PMID:18287403 |
| ammonium chloride | affects expression | ISO | RGD:2707 | 6480464 | Ammonium Chloride affects the expression of GLS mRNA | CTD | PMID:16483693 |
| arsenic atom | decreases activity | ISO | RGD:736636 | 6480464 | Arsenic results in decreased activity of GLS protein | CTD | PMID:19428935 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of GLS mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | increases expression | ISO | RGD:736636 | 6480464 | Benzo(a)pyrene results in increased expression of GLS mRNA | CTD | PMID:20106945 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:736636 | 6480464 | Benzo(a)pyrene results in increased expression of GLS mRNA | CTD | PMID:20106945 PMID:22316170 |
| benzo[a]pyrene | increases expression | ISO | RGD:736636 | 6480464 | Benzo(a)pyrene results in increased expression of GLS mRNA | CTD | PMID:20106945 |
| bisphenol A | affects expression | ISO | RGD:736636 | 6480464 | bisphenol A affects the expression of GLS mRNA | CTD | PMID:20170705 |
| calcitriol | decreases expression | ISO | RGD:736636 | 6480464 | Calcitriol results in decreased expression of GLS mRNA | CTD | PMID:16002434 |
| choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GLS mRNA | CTD | PMID:20938992 |
| cisplatin | increases expression | ISO | RGD:736636 | 6480464 | Cisplatin results in increased expression of GLS mRNA | CTD | PMID:19561079 |
| copper atom | increases expression | ISO | RGD:2707 | 6480464 | Copper results in increased expression of GLS mRNA | CTD | PMID:22465980 |
| copper(0) | increases expression | ISO | RGD:2707 | 6480464 | Copper results in increased expression of GLS mRNA | CTD | PMID:22465980 |
| copper(2+) sulfate | increases expression | ISO | RGD:736636 | 6480464 | Copper Sulfate results in increased expression of GLS mRNA | CTD | PMID:19549813 |
| coumestrol | decreases expression | ISO | RGD:736636 | 6480464 | Coumestrol results in decreased expression of GLS mRNA | CTD | PMID:19167446 |
| cyclophosphamide | increases expression | ISO | RGD:736636 | 6480464 | Cyclophosphamide results in increased expression of GLS mRNA | CTD | PMID:21527772 |
| cyclophosphamide | affects response to substance | ISO | RGD:736636 | 6480464 | GLS protein affects the susceptibility to Cyclophosphamide | CTD | PMID:16217747 |
| cyclosporin A | decreases expression | ISO | RGD:736636 | 6480464 | Cyclosporine results in decreased expression of GLS mRNA | CTD | PMID:22147139 |
| cytarabine | decreases expression | ISO | RGD:736636 | 6480464 | Cytarabine results in decreased expression of GLS mRNA | CTD | PMID:21198554 |
| diarsenic trioxide | increases expression | ISO | RGD:736636 | 6480464 | arsenic trioxide results in increased expression of GLS mRNA | CTD | PMID:20458559 |
| diuron | decreases expression | ISO | RGD:2707 | 6480464 | Diuron results in decreased expression of GLS mRNA | CTD | PMID:21551480 |
| folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GLS mRNA | CTD | PMID:20938992 |
| formaldehyde | increases expression | ISO | RGD:736636 | 6480464 | Formaldehyde results in increased expression of GLS mRNA | CTD | PMID:20655997 |
| hydrogen chloride | multiple interactions | EXP | | 6480464 | [Hydrochloric Acid results in decreased expression of GLS protein] which results in increased secretion of Ammonia | CTD | PMID:20719974 |
| hydrogen chloride | increases expression | EXP | | 6480464 | Hydrochloric Acid results in increased expression of GLS protein | CTD | PMID:20719974 |
| hydrogen peroxide | affects expression | ISO | RGD:736636 | 6480464 | Hydrogen Peroxide affects the expression of GLS mRNA | CTD | PMID:20044591 |
| hydrogen peroxide | multiple interactions | ISO | RGD:736636 | 6480464 | [Hydrogen Peroxide co-treated with Theophylline] results in increased expression of GLS protein | CTD | PMID:18951874 |
| indomethacin | decreases expression | ISO | RGD:736636 | 6480464 | Indomethacin results in decreased expression of GLS mRNA | CTD | PMID:16984733 |
| L-ascorbic acid | multiple interactions | ISO | RGD:736636 | 6480464 | [Quercetin co-treated with Ascorbic Acid] results in decreased expression of GLS mRNA | CTD | PMID:17639512 |
| L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GLS mRNA | CTD | PMID:20938992 |
| lactacystin | multiple interactions | ISO | RGD:736636 | 6480464 | lactacystin inhibits the reaction [diphenylarsinic acid results in increased degradation of GLS protein alternative form] | CTD | PMID:22493432 |
| lead(0) | decreases activity | ISO | RGD:2707 | 6480464 | Lead results in decreased activity of GLS protein | CTD | PMID:15149801 |
| lithium atom | multiple interactions | ISO | RGD:2707 | 6480464 | Lithium inhibits the reaction [Methamphetamine results in decreased expression of GLS mRNA] | CTD | PMID:19149911 |
| menadione | affects expression | ISO | RGD:736636 | 6480464 | Vitamin K 3 affects the expression of GLS mRNA | CTD | PMID:20044591 |
| methamphetamine | multiple interactions | ISO | RGD:2707 | 6480464 | Lithium inhibits the reaction [Methamphetamine results in decreased expression of GLS mRNA]; more ... | CTD | PMID:19149911 |
| methamphetamine | decreases expression | ISO | RGD:2707 | 6480464 | Methamphetamine results in decreased expression of GLS mRNA | CTD | PMID:19149911 |
| methyl methanesulfonate | increases expression | ISO | RGD:736636 | 6480464 | Methyl Methanesulfonate results in increased expression of GLS mRNA | CTD | PMID:21527772 |
| methylmercury chloride | increases activity | ISO | RGD:2707 | 6480464 | methylmercuric chloride results in increased activity of GLS protein | CTD | PMID:22223486 |
| methylmercury chloride | multiple interactions | ISO | RGD:2707 | 6480464 | Polyphenols inhibits the reaction [methylmercuric chloride results in increased activity of GLS protein] | CTD | PMID:22223486 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:2707 | 6480464 | [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of GLS mRNA | CTD | PMID:20360939 |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of GLS mRNA | CTD | PMID:17562736 |
| paracetamol | increases expression | ISO | RGD:736636 | 6480464 | Acetaminophen results in increased expression of GLS mRNA | CTD | PMID:21420995 |
| phenylarsonic acid | decreases expression | ISO | RGD:736636 | 6480464 | benzenearsonic acid results in decreased expression of GLS protein | CTD | PMID:19428935 |
| phenylarsonic acid | decreases activity | ISO | RGD:736636 | 6480464 | benzenearsonic acid results in decreased activity of GLS protein | CTD | PMID:19428935 |
| quercetin | multiple interactions | ISO | RGD:736636 | 6480464 | [Quercetin co-treated with Ascorbic Acid] results in decreased expression of GLS mRNA | CTD | PMID:17639512 |
| quercetin | increases expression | ISO | RGD:736636 | 6480464 | Quercetin results in increased expression of GLS mRNA | CTD | PMID:21632981 |
| theophylline | multiple interactions | ISO | RGD:736636 | 6480464 | [Hydrogen Peroxide co-treated with Theophylline] results in increased expression of GLS protein | CTD | PMID:18951874 |
| troglitazone | increases expression | ISO | RGD:736636 | 6480464 | troglitazone results in increased expression of GLS mRNA | CTD | PMID:19140230 |
| undecane | decreases expression | ISO | RGD:2707 | 6480464 | undecane results in decreased expression of GLS protein | CTD | PMID:17337753 |
| valproic acid | multiple interactions | ISO | RGD:2707 | 6480464 | Valproic Acid inhibits the reaction [Methamphetamine results in decreased expression of GLS mRNA] | CTD | PMID:19149911 |